Akari Therapeutics Security Sold Not Yet Repurchased (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2535 -0.01 (-3.94%) USD | NASDAQ | Jan 21, 12:48

View Security Sold Not Yet Repurchased (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Security Sold Not Yet Repurchased (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Security Sold Not Yet Repurchased (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Security Sold Not Yet Repurchased (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	--
Cellectis SA	--
Biodexa Pharmaceuticals Plc	--
NuCana Plc	--
Autolus Therapeutics Plc	--